The European Association of Nuclear Medicine (EANM) represents a medical specialty where clinical outcomes are inseparable from high-fidelity data. We welcome the European Commissions move to streamline the Unions digital regulatory framework through the Digital Omnibus.
EAN
European Association of Nuclear Medicine
NGO · Austria · EU Transparency Register 348978437245-85
6
positions filed
in the 665 files tracked
5
legislative files
of 665 tracked
5
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1106 non-governmental organisations on this site, they rank #254 by legislative files engaged, a count of participation, not a measure of influence.
2.4
declared lobbying FTE
self-declared
–
declared costs / yr (floor)
2
EP accreditations
as declared to the register
2020
in the register since
Declares membership of
- European Cancer Organisation - https://www.europeancancer.org/
- European Alliance for Medical Radiation Protection Research (EURAMED) - https://www.euramed.eu/
- European Institute for Biomedical Imaging Research (EIBIR) - https://www.eibir.org/
- Coalition for Reducing Bureaucracy in Clinical Trials - https://bureaucracyincts.eu/
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Non-governmental organisations
- Head office
- Vienna, Austria
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track European in PolicySpeak: request access →
Work at European Association of Nuclear Medicine? so we know who speaks for it.
Their record over time
European Association of Nuclear Medicine filed 6 positions between 27 Apr 2021 and 19 Jun 2026, across 5 of the 665 legislative files tracked here, attaching a full position paper 5 times.
2021 · 1 filed2023 · 1 filed2026 · 4 filed
What they argued
The European Association for Nuclear Medicine (EANM) welcomes the European Commissions proposal for a revision of the Medical Device Regulation (MDR). The MDR has been crucial for healthcare professionals (HCPs), including for the nuclear medicine community, as it establishes a robust framework to ensure the safety, quality, and performance of medical devices used in diagnostics and therapy.
The European Association for Nuclear Medicine (EANM) welcomes the European Commission´s initiative for a revision of the pharmaceutical legislation package for the European Union. Nuclear Medicine is a powerful tool for diagnosis and treatment of a variety of diseases and has seen a tremendous development, especially in the last two decades.
EANM highly appreciates the initiative to revise the legislative framework for medicinal products in Europe and takes the chance to highlight aspects of significant importance for the application of Nuclear Medicine technology.
The European Association of Nuclear Medicine (EANM) strongly supports the objectives of the Act and welcomes the European Commissions aims to strengthen Europes biotechnology ecosystem, improve competitiveness and advance innovation.
As the largest non-profit medical organisation dedicated to nuclear medicine in Europe and bringing together nuclear medicine professionals from a range of medical specialties, the European Association of Nuclear Medicine appreciates the opportunity to give input through this consultation.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put European Association of Nuclear Medicine next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 133.
Is this your organization?
Everything on this page comes from European Association of Nuclear Medicine’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.